Instil Bio, Inc.

Stage 4 · Declining · week 23

As of Oct 22, 2026, Instil Bio is in Stage 4, the downtrend phase, now in week 23 (since May 13, 2026). It closed at $5.70, 71.3% below its 52-week high and below its 200-day average, which is falling.

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. More about the company

$5.70

-1.21% today

$38.7M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is TIL early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 22w

S2 18w

S4 16w

S4 23w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 22w → S1 5w → S2 8w → S3 12w → S2 18w → S3 11w → S4 16w → S1 6w → S2 6w → S3 9w → S4 23w → S1 5w → S4 23w current

Total tracked: 166 weeks across 13 stage runs.

TIL among Biotechnology432nd of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…432	TILInstil Bio, Inc.	Stage 4 · wk 23	15	−21.2%

vs 52W High

-71.3%

$5.70 lo$19.87 hi

71.3% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 23

1w13w26w

Week 23, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-26.1%

200 DMA: $7.71 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

4.14x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-21.2%

-20.1%

-30.3%

YTD

-49.4%

-70.0%

Scan Membership

Breakout Watch

Latest: 2024-07-22

2 appearances in last 60 days. First seen: 2024-02-26.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 23 · Vol 4.14x

2026-10-21S4

Wk 23 · Vol 2.02x

2026-10-20S4

Wk 23 · Vol 5.62x

2026-10-19S4

Wk 22 · Vol 9.71x

2026-10-16S4

Wk 22 · Vol 1.72x

2026-10-15S4

Wk 22 · Vol 2.32x

2026-10-14S4

Wk 22 · Vol 3.25x

2026-10-13S4

Wk 22 · Vol 2.09x

2026-10-12S4

Wk 21 · Vol 0.86x

2026-10-09S4

Wk 21 · Vol 2.98x

2026-10-08S4

Wk 21 · Vol 4.68x

2026-10-07S4

Wk 21 · Vol 0.63x

Moving averages & range

50 DMA

$7.09

200 DMA

$7.71

52W High

$19.87

52W Low

$5.70

5D Low

$5.70

Resistance levels (recent highs)

20d High

$7.24

60d High

$7.86

120d High

$8.23

250d High

$19.87

Next resistance

+27.0%

to 20d High

ROE

-25.3%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.4

Instil Bio: quick answers

What stage is Instil Bio in?

As of Oct 22, 2026, Instil Bio (TIL) is in Stage 4, the downtrend phase. It entered Stage 4 on May 13, 2026 and is in week 23. What the four stages mean

Is Instil Bio in an uptrend?

No. Instil Bio is in a Stage 4 downtrend. It trades 26.1% below its 200-day average, which is falling.

How far is Instil Bio from its 52-week high?

Instil Bio closed at $5.70 on Oct 22, 2026, 71.3% below its 52-week high of $19.87. Its 52-week low is $5.70.

How has Instil Bio performed over the past year?

As of Oct 22, 2026, Instil Bio is down 70.0% over the past year and down 49.4% so far in 2026.

Which sector and industry is Instil Bio in?

Instil Bio is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.